|
Volumn 61, Issue 7, 2001, Pages 3033-3038
|
1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): A novel sulfonylhydrazine prodrug with bbroad-spectrum antineoplastic activity
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
1,2 BIS(METHYLSULFONYL) 1 (2 CHLOROETHYL) 2 (METHYLAMINO)CARBONYLHYDRAZINE;
101M;
CARMUSTINE;
CYCLOPHOSPHAMIDE;
HYDRAZINE DERIVATIVE;
MELPHALAN;
PRODRUG;
UNCLASSIFIED DRUG;
ADVANCED CANCER;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BLOOD BRAIN BARRIER;
BONE MARROW SUPPRESSION;
COLON CARCINOMA;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG SAFETY;
DRUG SYNTHESIS;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
SURVIVAL TIME;
TUMOR XENOGRAFT;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CARMUSTINE;
DRUG SCREENING ASSAYS, ANTITUMOR;
FEMALE;
HUMANS;
HYDRAZINES;
LEUKEMIA L1210;
MELANOMA, EXPERIMENTAL;
MICE;
MICE, INBRED BALB C;
NITROSO COMPOUNDS;
PRODRUGS;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 0035300422
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (72)
|
References (35)
|